Hyperuricemia

There are 280 papers on hyperuricemia in aging research: 17 trials and 204 observational studies in people, 9 in animals, 1 in cells, 46 reviews.

Disease

280 papers study it109 more mention it161 findings

MeSH

33 new papers in 30 daysSee all 389 papers on hyperuricemia

“hyperuricemia risk almost doubled with BA (RR 1.93, 95 % CI 1.75–2.14)”
Bempedoic Acid Lowers LDL-C and Reduces Risk of Major Cardiovascular Events in Hypercholesterolemia: Meta-Analysis of 13 Randomized Controlled TrialsAHA Scientific Sessions 2025 abstract2025doi:10.1161/circ.152.suppl_3.4372102
  • Human trial17
  • Humans204
  • Animals8
  • Model organisms1
  • Cells1

Interventions

2

Bariatric-metabolic surgery combined with continuity of care

downin humans1−95% remission

1 study
  1. Bariatric-metabolic surgery combined with continuity of care is linked with lower hyperuricemia in humans (patients with obesity and hyperuricemia) (94.62% remission).

    “At 12 months, remission rates were 69.57 % for hypertension, 94.62 % for hyperuricemia,”

    Humanspatients with obesity and hyperuricemia12 months

    Effect of bariatric-metabolic surgery combined with continuity of care on the remission of metabolic diseases in patients with obesity

    Nutricion hospitalaria

More on Bariatric-metabolic surgery combined with continuity of care

Adrenalectomy

no changein humans1

1 study
  1. Adrenalectomy was not clearly linked with hyperuricemia in patients with primary aldosteronism compared with matched controls (aHR 1.92; 95% CI, 0.82-4.52; p = 0.424).

    “while the elevated risk of hyperuricemia did not reach statistical significance (aHR 1.92; 95% CI, 0.82-4.52; p = 0.424)”

    Humansin patients with primary aldosteronism compared with matched controls20 years

    Chronic kidney disease, hyperuricemia, and gout after adrenalectomy for primary aldosteronism: a 20-year population-based study

    Journal of endocrinological investigation

More on Adrenalectomy

Effects

9

Possible sarcopenia

no changein humans1

1 study
  1. Hyperuricemia was not clearly linked with possible sarcopenia in humans (without metabolic syndrome) (P>0.05).

    “However, in older men without metabolic syndrome, no significant relationship was found between hyperuricemia and possible sarcopenia (P>0.05).”

    Humanswithout metabolic syndromemalesn = 1,604

    Correlation between Hyperuricemia and Decreased Handgrip Strength in Korean Men Aged 65 Years and Older with Metabolic Syndrome: Seventh Korea National Health and Nutrition Examination Survey, 2016–2018

    Korean Journal of Family Practice

More on Possible sarcopenia

SCORE2

no changein humans1

1 study
  1. Hyperuricemia was not clearly linked with SCORE2 in humans (non-diabetic hypertensive patients).

    “There was no significant difference in the median SCORE2 in patients with or without hyperuricemia.”

    Humansnon-diabetic hypertensive patientsn = 588

    Hyperuricemia is not associated to cardiovascular risk assessed using SCORE2 in non-diabetic hypertensive patients aged 40 to 69 years in North Cameroon

    Annales de cardiologie et d'angeiologie

More on SCORE2

Estimated glomerular filtration rate

downin humans1

1 study
  1. Hyperuricemia is linked with lower estimated glomerular filtration rate in humans (healthy participants).

    “Baseline SUA ≥ 7 mg/dL was associated with higher baseline eGFR but predicted a significantly faster subsequent eGFR decline.”

    Humanshealthy participants

    Differential associations of transient hyperuricemia and transient hypouricemia with annual changes in estimated glomerular filtration rate in healthy participants: an observational study

    BMC nephrology

More on Estimated glomerular filtration rate

NAD+

downin reviews1

1 study
  1. Hyperuricemia decreases NAD+.

    “oxidative stress, mitochondrial dysfunction, and inflammation from HU can indirectly deplete intracellular NAD+ by increasing the activity of NAD+-consuming enzymes”

    Review

    The interplay of NAD+, hyperuricemia, and renal damage: A scientific review

    Pathology, research and practice

More on NAD+

Low muscle mass

no changein humans1

1 study
  1. Hyperuricemia was not clearly linked with low muscle mass in humans.

    “In the male cohort, neither SUA levels nor hyperuricemia demonstrated a significant association with low muscle mass.”

    Humansmalesn = 1,121

    Association between serum uric acid, hyperuricemia and low muscle mass in middle-aged and elderly adults: A national health and nutrition examination study

    PloS one

Handgrip strength

downin humans1

1 study
  1. Hyperuricemia is linked with lower handgrip strength in humans (p = 0.00028).

    “Women with hyperuricemia presented significant association with lower HGS (p = 0.00028).”

    Humansfemalesn = 422

    Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women

    Climacteric : the journal of the International Menopause Society

Cardiovascular disease

no changein humans1

1 study
  1. Hyperuricemia was not clearly linked with cardiovascular disease in humans among the Miao ethnic group.

    “But a positive association was not found among the Miao ethnic group.”

    Humansamong the Miao ethnic group

    A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults

    Scientific reports

More on Cardiovascular disease

Osteoporosis

downin humans1OR 0.69

1 study
  1. Hyperuricemia is linked with less osteoporosis in humans (OR = 0.69; 95%CI: 0.53-0.91).

    “while resulted protective for osteoporosis (OR = 0.69; 95%CI: 0.53-0.91).”

    Humansfemales

    Hyperuricemia, Cardiovascular Profile, and Comorbidity in Older Men and Women: The Pro.V.A. Study

    Rejuvenation research

More on Osteoporosis

Lower extremity function

downin humans1

1 study
  1. Hyperuricemia is linked with worse lower extremity function in humans.

    “Similarly, SPPB score and walking speed, but not grip strength, were worse in participants with hyperuricemia.”

    Humansn = 5,819

    Physical Function, Hyperuricemia, and Gout in Older Adults

    Arthritis care & research

Associations

112

Mortality

upin humans6HR 1.25–3.08

6 studies
  1. Hyperuricemia predicts mortality in humans (HR 3.08, 95% CI 1.31-7.26).

    “Sex-stratified studies indicated that hyperuricemia persisted as an independent predictor of mortality in females (HR: 3.08, 95% CI: 1.31-7.26, P = 0.010).”

    Humansfemales

    Uric Acid and Grip Strength as Predictors of Mortality in Older Adults: A Sex-Stratified Analysis

    Metabolic syndrome and related disorders

  2. Hyperuricemia predicts mortality in humans (combined with vitamin D deficiency in cardiovascular disease patients) (HR 1.96 (1.47-2.62)).

    “Patients with both HUA and VDD exhibited the highest risk of all-cause mortality (HR 1.96 (1.47-2.62), P for trend < 0.01).”

    Humanscombined with vitamin D deficiency in cardiovascular disease patientsn = 3,360

    Joint Association of Hyperuricemia and Vitamin D Deficiency with Cardiovascular Disease Risk and All-Cause Mortality

    International heart journal

  3. Hyperuricemia is linked with a higher risk of mortality in humans.

    “hyperuricemia, which was more common in men, older women, and urban residents, and was associated with increased risks of gout, all-cause mortality, and several cardiometabolic, renal, digestive, and musculoskeletal diseases.”

    Humansn = 16,817

    Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults

    The Lancet regional health. Western Pacific

  4. Hyperuricemia is linked with a higher risk of mortality in humans (HR 1.25, 95% CI 1.01-1.55).

    “After adjusting for covariates, MDS ≥2 (HR=1.34, 95% CI: 1.13-1.60) and hyperuricemia (HR=1.25, 95% CI: 1.01-1.55) were associated with increased odds of all-cause mortality.”

    Humansaverage of 81 months of follow-up

    Association between dietary magnesium intake, magnesium depletion score and hyperuricemia-related all-cause mortality or cardiovascular mortality in patients with coronary heart disease

    Magnesium research

  5. Hyperuricemia is associated with mortality in humans (SUA ≥420 μmol/L compared with normouricaemic individuals (SUA <360 μmol/L)) (HR 1.32 (95% CI 1.05 to 1.60)).

    “The adjusted HR for all-cause mortality among clearly hyperuricaemic individuals with SUA≥420 μmol/L compared with normouricaemic individuals (SUA<360 μmol/L) was 1.32 (95% CI 1.05 to 1.60) in women”

    HumansSUA ≥420 μmol/L compared with normouricaemic individuals (SUA <360 μmol/L)females

    Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population

    BMJ open

  6. Hyperuricemia is linked with a higher risk of mortality in humans (hip fracture after surgery).

    “hyperuricemia or gout was associated with increased death risk”

    Humanship fracture after surgeryn = 742

    The paradoxical relation between serum uric acid and outcomes of hip fracture in older patients after surgery: A 1-year follow-up study

    Surgery

Cardiovascular disease

upin humans5OR 1.49–1.67

5 studies
  1. Hyperuricemia is associated with cardiovascular disease in humans (combined with vitamin D deficiency) (OR 1.50 (1.17-1.83)).

    “The participant group with both HUA and VDD exhibited the highest risk of CVD (OR 1.50 (1.17-1.83), P for trend < 0.01).”

    Humanscombined with vitamin D deficiencyn = 30,337

    Joint Association of Hyperuricemia and Vitamin D Deficiency with Cardiovascular Disease Risk and All-Cause Mortality

    International heart journal

  2. Hyperuricemia is associated with cardiovascular disease in humans following diabetes (OR 1.67, 95% CI 1.15–2.43).

    “1.67 times higher odds (OR:1.67; 95% CI, 1.15, 2.43) of incident cardiovascular diseases following diabetes.”

    Humansfollowing diabetesaround 7 yearsn = 4,820

    Change of serum uric acid and progression of cardiometabolic multimorbidity among middle aged and older adults: A prospective cohort study

    Frontiers in public health

  3. Hyperuricemia is associated with cardiovascular disease in humans (Bouyei ethnicity) (OR 1.66 (95% CI 1.06-2.59)).

    “Among women, HUA was positively associated with the risk of stroke in Dong ethnicity and CVDs in Bouyei ethnicity (ORs (95% CIs) 2.02 (1.07-3.81) and 1.66 (1.06-2.59)) compared with non-HUA.”

    HumansBouyei ethnicityfemales

    Hyperuricemia is Related to the Risk of Cardiovascular Diseases in Ethnic Chinese Elderly Women

    Global heart

  4. Hyperuricemia is linked with a higher risk of cardiovascular disease in humans (Dong ethnicity) (55% increased risk (OR 1.55, 95% CI 1.00-2.39)).

    “After stratification by sex and the median age, for women aged > 50 years, a 55% (1.55, 1.00-2.39) and 65% (1.65, 1.02-2.66) increased risk for CVDs was observed in Dong and Bouyei ethnicities.”

    HumansDong ethnicityfemales

    Hyperuricemia is Related to the Risk of Cardiovascular Diseases in Ethnic Chinese Elderly Women

    Global heart

  5. Hyperuricemia is linked with a higher risk of cardiovascular disease in rural residents of Dong and Bouyei ethnic groups (adjusted OR 1.49, 95% CI 1.06-2.08 (Dong); 1.55, 1.07-2.25 (Bouyei)).

    “Compared to urban residents, an at least 49% increased CVD risk (adjusted OR 1.49, 95%CI 1.06-2.08 for the Dong ethnic group; 1.55, 1.07-2.25 for the Bouyei ethnic group)”

    Humansin rural residents of Dong and Bouyei ethnic groups

    A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults

    Scientific reports

  6. Hyperuricemia is associated with cardiovascular disease in humans after adjustment for age, body mass index, and renal function.

    “HU was independently associated with the presence of cardiovascular diseases in both sexes.”

    Humansafter adjustment for age, body mass index, and renal function

    Hyperuricemia, Cardiovascular Profile, and Comorbidity in Older Men and Women: The Pro.V.A. Study

    Rejuvenation research

More on Cardiovascular disease

Stroke

upin humans5RR 1.2

5 studies
  1. Hyperuricemia is linked with a higher risk of stroke in humans (RR = 1.20, 95%CI: 1.11-1.29).

    “Conventional meta-analysis showed that hyperuricemia was significantly associated with stroke incidence (RR = 1.20, 95%CI: 1.11-1.29)”

    Humans

    Evidence for a dose-response association of hyperuricemia with stroke incidence: a meta-analysis of cohort studies

    Frontiers in neurology

  2. Hyperuricemia is linked with a higher risk of stroke in humans (Chinese adults) (OR = 4.07, 95% CI: 1.25-13.19).

    “Hyperuricemia was positively associated with frailty status (OR = 1.54, 95% CI: 1.02-5.84) and with the incidence of stroke (OR = 4.07, 95% CI: 1.25-13.19).”

    HumansChinese adultsn = 7,462

    Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study

    Clinical and experimental hypertension (New York, N.Y. : 1993)

  3. Hyperuricemia is associated with stroke in humans (Dong ethnicity) (OR 2.02 (95% CI 1.07-3.81)).

    “Among women, HUA was positively associated with the risk of stroke in Dong ethnicity and CVDs in Bouyei ethnicity (ORs (95% CIs) 2.02 (1.07-3.81) and 1.66 (1.06-2.59)) compared with non-HUA.”

    HumansDong ethnicityfemales

    Hyperuricemia is Related to the Risk of Cardiovascular Diseases in Ethnic Chinese Elderly Women

    Global heart

  4. Hyperuricemia is linked with a higher risk of stroke in rural areas among the Dong ethnic group (OR 1.79, 95% CI 1.02-3.13 (elderly); 2.24, 1.09-4.62 (women)).

    “furthermore, an at least 79% increased risk of stroke related to HUA was observed in women (2.24, 1.09-4.62) and elderly people (1.79, 1.02-3.13) in rural areas among the Dong ethnic group.”

    Humansin rural areas among the Dong ethnic group

    A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults

    Scientific reports

  5. Hyperuricemia is linked with a higher risk of stroke in humans (without comorbidities) (HR = 2.32, 95%CI 1.56-3.45).

    “Cox regression showed that hyperuricemia independently predicted incident stroke risk (HR = 2.32, 95%CI 1.56-3.45).”

    Humanswithout comorbidities35.5 ± 3.0 monthsn = 3,243

    Asymptomatic hyperuricemia and incident stroke in elderly Chinese patients without comorbidities

    European journal of clinical nutrition

More on Stroke

Type 2 diabetes

upin humans2no changein humans1upin rats1OR 1.02–2.01

4 studies
  1. Type 2 diabetes is associated with hyperuricemia in humans After adjustment (OR 1.02; p-FDR = 0.782).

    “the diabetes–hyperuricemia association was fully attenuated after adjustment (OR = 1.02; p -FDR = 0.782).”

    HumansAfter adjustmentFive yearsn = 8,383

    Comorbidity Patterns and Temporal Pathways in Metabolic Multimorbidity: A Five-Year Retrospective Cohort Study of Dyslipidemia, Hyperuricemia, Obesity, and Diabetes

    Research SquarePreprint

  2. Hyperuricemia is associated with type 2 diabetes in humans (OR 2.01, 95% CI 1.18–3.43).

    “Specifically, keeping or rising to hyperuricemia (vs. keeping or declining to non-hyperuricemia) was associated with 2.01 times higher odds (95% CI, 1.18, 3.43) of incident diabetes”

    Humansaround 7 yearsn = 4,820

    Change of serum uric acid and progression of cardiometabolic multimorbidity among middle aged and older adults: A prospective cohort study

    Frontiers in public health

  3. Type 2 diabetes is associated with hyperuricemia in humans (elderly agricultural and fishing professionals) (OR 1.54, 95% CI 1.22–1.93).

    “type 2 diabetes (OR=1.54, 95% CI: 1.22-1.93) and high alanine amino transferase levels (OR=1.79, 95% CI: 1.31-2.43) were significantly associated with hyperuricemia in females.”

    Humanselderly agricultural and fishing professionalsfemalesn = 1,606

    Prevalence and Metabolic Factors of Hyperuricemia in an Elderly Agricultural and Fishing Population in Taiwan

    Archives of rheumatology

  4. Hyperuricemia raises the risk of type 2 diabetes in rats (uricase deficiency).

    “In conclusion, it demonstrated that hyperuricemia in KDY rats leads to type 2 diabetes mellitus (hyperglycemia), hyperlipidemia, atherosclerosis, and hypertension, in addition to gouty nephropathy.”

    Animalsuricase deficiency

    Uricase deficiency in rats results in a variety of metabolic disorders, addition to gouty nephropathy

    PloS one

More on Type 2 diabetes

Chronic kidney disease

upin humans2upin reviews1OR 2.9

3 studies
  1. Hyperuricemia is linked with a higher risk of chronic kidney disease in elderly diabetic males.

    “The adjusted HRs of hyperuricemia for new-onset CKD were 1.925 (1.724-2.150) and 1.676 (1.520-1.848) for males and females, respectively.”

    Humansin elderly diabetic males2-yearmales

    Serum uric acid is associated with chronic kidney disease in elderly Chinese patients with diabetes

    Renal failure

  2. Hyperuricemia is associated with chronic kidney disease in humans (synergy index, 1.7).

    “Furthermore, hyperuricemia and HHcy had significant synergistic association (synergy index, 1.7) with CKD.”

    Humansn = 5,910

    Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population

    Medicine

  3. Hyperuricemia is linked with a higher risk of chronic kidney disease in humans (OR 2.9).

    “Both hyperuricemia (OR 2.9) and Q4 of Hcy (OR 8.1) were significant independent risk factors for CKD.”

    Humansn = 5,910

    Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population

    Medicine

  4. Hyperuricemia is associated with chronic kidney disease.

    “Hyperuricemia (HU) is a common metabolic disorder associated with the development of chronic kidney disease (CKD)”

    Review

    The interplay of NAD+, hyperuricemia, and renal damage: A scientific review

    Pathology, research and practice

More on Chronic kidney disease

Body mass index

upin humans3

3 studies
  1. Body mass index is associated with hyperuricemia in humans (Body mass index ≥25; stronger association in postmenopause than premenopause) (Hyperuricemia in approximately 18% of overweight or obese women at menopause).

    “the associations of a low estimated glomerular filtration rate (<60 mL/min per 1.73 m2) and a high body mass index (≥25) with HU were greater in postmenopause”

    HumansBody mass index ≥25; stronger association in postmenopause than premenopausefemales

    Longitudinal Changes in Serum Urate Levels From Premenopause Through Postmenopause: Interrupted Time-Series Analyses

    Arthritis & rheumatology (Hoboken, N.J.)

  2. Body mass index is linked with a higher risk of hyperuricemia in humans (normal baseline uric acid levels).

    “Significant associations with HUA were observed for body mass index (BMI), waist circumference (WC), body roundness index (BRI), cardiometabolic index (CMI), visceral adiposity index (VAI), Chinese visceral adiposity index (CVAI)”

    Humansnormal baseline uric acid levelsthree-year periodn = 4,112

    Identifying reliable obesity indices for hyperuricemia among middle-aged and elderly populations: a longitudinal study

    Lipids in health and disease

  3. Body mass index is linked with a higher risk of hyperuricemia in humans after adjusting for confounding variables.

    “BMI, WC, WHtR, BRI, and CI were significantly associated with incident HUA in women but not in men.”

    Humansafter adjusting for confounding variables4-yearfemalesn = 5,873

    Sex-specific differences in the associations between adiposity indices and incident hyperuricemia among middle-aged and older adults: a nationwide longitudinal study

    Frontiers in endocrinology

More on Body mass index

Lipid Accumulation Product

upin humans2

2 studies
  1. Lipid Accumulation Product predicts hyperuricemia in humans.

    “The results from the ROC curves indicate that LAP may serve as a better predictor of HUA in males”

    Humansthree-year periodmales

    Identifying reliable obesity indices for hyperuricemia among middle-aged and elderly populations: a longitudinal study

    Lipids in health and disease

  2. Lipid Accumulation Product predicts hyperuricemia in humans (AUC 0.612).

    “LAP had the highest area under the curve (AUC) (0.612) followed by CVAI (0.596) in men”

    Humans4-yearmalesn = 5,873

    Sex-specific differences in the associations between adiposity indices and incident hyperuricemia among middle-aged and older adults: a nationwide longitudinal study

    Frontiers in endocrinology

  3. Lipid Accumulation Product is linked with a higher risk of hyperuricemia in humans after adjusting for confounding variables.

    “After adjusting for confounding variables, LAP, VAI, and CVAI showed significant association with incident HUA.”

    Humansafter adjusting for confounding variables4-yearn = 5,873

    Sex-specific differences in the associations between adiposity indices and incident hyperuricemia among middle-aged and older adults: a nationwide longitudinal study

    Frontiers in endocrinology

More on Lipid Accumulation Product

C-reactive protein

upin humans2

2 studies
  1. Hyperuricemia is associated with C-reactive protein in humans (axial spondyloarthritis, psoriatic arthritis, and controls; not rheumatoid arthritis).

    “Hyperuricemia correlated with higher hsCRP levels in axial spondyloarthritis, psoriatic arthritis, and controls, but not in rheumatoid arthritis.”

    Humansaxial spondyloarthritis, psoriatic arthritis, and controls; not rheumatoid arthritis

    Hyperuricemia, disease activity, and 10-year cardiovascular risk in chronic inflammatory arthritis: a post-hoc analysis of the CARMA project

    Rheumatology (Oxford, England)

  2. Hyperuricemia is associated with C-reactive protein in humans.

    “hyperuricemia was significantly associated with inflammation, registered by high-sensitivity C-reactive protein in both sexes.”

    Humans

    Inflammaging and Vascular Function in Metabolic Syndrome: The Role of Hyperuricemia

    Medicina (Kaunas, Lithuania)

More on C-reactive protein

Major adverse cardiovascular events

upin humans2OR 1.87–5.77

2 studies
  1. Hyperuricemia predicts major adverse cardiovascular events in humans (chronic inflammatory arthritis; baseline serum urate >6.8 mg/dL) (Adjusted OR 1.87, 95% CI 1.23–2.86).

    “Hyperuricemia independently increased the risk of MACE in CIA (adjusted OR 1.87, 95% CI 1.23-2.86)”

    Humanschronic inflammatory arthritis; baseline serum urate >6.8 mg/dL10 yearsn = 1,552

    Hyperuricemia, disease activity, and 10-year cardiovascular risk in chronic inflammatory arthritis: a post-hoc analysis of the CARMA project

    Rheumatology (Oxford, England)

  2. Hyperuricemia is linked with a higher risk of major adverse cardiovascular events in patients with type 2 diabetes (34.2% vs 8.6%; adjusted OR 5.77).

    “showed a significantly higher incidence of MACE than those without hyperuricemia (34.2% vs 8.6%; adjusted odds ratio 5.77, 95% CI: 2.49-13.39)”

    Humansin patients with type 2 diabetes

    Empagliflozin improves serum uric acid and early cardiometabolic outcomes in asymptomatic hyperuricemia among patients with type 2 diabetes: A 6-month observational study

    Medicine

More on Major adverse cardiovascular events

ABCG2

upin humans2OR 2.198

2 studies
  1. ABCG2 is associated with hyperuricemia in humans (ABCG2 rs2231142 GT/TT vegetarians compared with GG-carrier vegetarians) (OR 2.198, 95% CI 1.369–3.528; p = 0.0011).

    “Compared to GG-carrier vegetarians, the adjusted odds ratios for HUA were 2.198 (95% CI: 1.369-3.528, p = 0.0011) among GT/TT vegetarians”

    HumansABCG2 rs2231142 GT/TT vegetarians compared with GG-carrier vegetarians

    The interaction between ABCG2 rs2231142 polymorphism and vegetarian diet on the prevalence of hyperuricemia in a large Taiwanese cohort

    Genes & nutrition

  2. ABCG2 is linked with a higher risk of hyperuricemia in humans (PAF 32.8%).

    “the PAF for hyperuricemia due to ABCG2 dysfunction (32.8%) exceeded those for overweight/obesity (19.5%) and aging (28.7%)”

    Humansfemales

    Effects of ABCG2 dysfunction on hyperuricemia progression in premenopausal and postmenopausal women

    Human cell

More on ABCG2

Bempedoic acid

upin humans1RR 1.93

1 study
  1. Bempedoic acid raises the risk of hyperuricemia in humans (hypercholesterolemia) (RR 1.93 (95% CI 1.75–2.14)).

    “hyperuricemia risk almost doubled with BA (RR 1.93, 95 % CI 1.75–2.14)”

    Human trialhypercholesterolemia

    Bempedoic Acid Lowers LDL-C and Reduces Risk of Major Cardiovascular Events in Hypercholesterolemia: Meta-Analysis of 13 Randomized Controlled Trials

    AHA Scientific Sessions 2025 abstract

More on Bempedoic acid

CD4+CD28null T cells

upin humans1

1 study
  1. Hyperuricemia is associated with CD4+CD28null T cells in humans (normouricemic controls comparison at baseline) (36.8% vs. 6.1%).

    “At baseline, hyperuricemic patients had more CD4+CD28null/CD4+ cells than normouricemic subjects (36.8% vs. 6.1%; p = 0.001)”

    Human trialnormouricemic controls comparison at baselineblood

    Senescent CD4⁺CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study

    Clinical rheumatology

More on CD4+CD28null T cells

Ciclosporin

upin humans1

1 study
  1. Ciclosporin raises the risk of hyperuricemia in humans (versus everolimus-based regimen).

    “A higher incidence of hyperuricaemia was noted with ciclosporin”

    Human trialversus everolimus-based regimen

    Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

    Lancet (London, England)

More on Ciclosporin

All 112

Trial sponsors

Latest

Dec 2025: 12Jan 2026: 21Feb 2026: 14Mar 2026: 11Apr 2026: 6May 2026: 8Jun 2026: 12Jul 2026: 15Aug 2026: 14Sep 2026: 12Oct 2026: 12Nov 2026: 16153 papers in 12 months

See all 389 papers on hyperuricemia